MedDataX Logo

The Effect of Obesity on Venous Puncture Pain

NCT ID: NCT03689205

Last Updated: 2018-09-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

70 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-06-20

Study Completion Date

2018-11-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Before surgery, patients will fill the Beck anxiety, distress tolerance test and Pain katastrophizing test. Patients will be divided into two groups according to BMI\> 30kg / m2 (Group A) and BMI \<30kg / m2 (Group B). Compared to body weight, venous vascular pain of the groups will be compared.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Seventy patients will be randomized to two groups(BMI\> 30kg / m2 (Group A) and BMI \<30kg / m2 (Group B) during peripheral venous cannulation (PVC). The patients' visual analog scores will be measured during peripheral venous cannulation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain Cannulation Body Mass Index

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients that BMI> 30kg / m2 (Group A)

Venous puncture pain on patients that Body mass index \> 30kg / m2

No interventions assigned to this group

Patients that BMI< 30kg / m2 (Group B)

Venous puncture pain on patients that Body mass index \< 30kg / m2

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* American Society of Anesthesiologist (ASA) physical status 1 and 2, between the ages of 18 and 65, were scheduled for elective surgery

Exclusion Criteria

* Patients with a history of anxiety disorders or hearing problem and preoperative pain, emergency surgery
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tokat Gaziosmanpasa University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hakan Tapar

Assist. Prof

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hakan Tapar

Role: PRINCIPAL_INVESTIGATOR

Gaziosmanpasa University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gaziosmanpasa University

Tokat Province, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hakan Tapar

Role: CONTACT

Phone: 03562129500

Email: [email protected]

Hakan Tapar

Role: CONTACT

Phone: 03562129500

Email: [email protected]

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Hakan Tapar, Assist.Prof.

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

18-KAEK-101

Identifier Type: -

Identifier Source: org_study_id